IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 194 filers reported holding IVERIC BIO INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $25,327,495 | +44.7% | 1,182,975 | +21.3% | 1.31% | +29.2% |
| Q3 2022 | $17,499,000 | +154.3% | 975,430 | +36.4% | 1.01% | +153.0% |
| Q2 2022 | $6,880,000 | -52.7% | 715,144 | -17.3% | 0.40% | -15.3% |
| Q1 2022 | $14,560,000 | -2.1% | 865,144 | -2.7% | 0.47% | -12.4% |
| Q4 2021 | $14,872,000 | +2782.2% | 889,454 | +2700.1% | 0.54% | +3268.8% |
| Q3 2021 | $516,000 | +70.3% | 31,765 | -33.9% | 0.02% | +77.8% |
| Q2 2021 | $303,000 | – | 48,065 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |